Charles Schwab Investment Management Inc. Has $33.94 Million Stake in Oscar Health, Inc. (NYSE:OSCR)

Charles Schwab Investment Management Inc. raised its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 20.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,600,166 shares of the company's stock after purchasing an additional 270,223 shares during the period. Charles Schwab Investment Management Inc. owned 0.66% of Oscar Health worth $33,940,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Intech Investment Management LLC acquired a new position in shares of Oscar Health in the third quarter valued at $1,282,000. Swiss National Bank grew its stake in shares of Oscar Health by 17.8% in the third quarter. Swiss National Bank now owns 314,900 shares of the company's stock valued at $6,679,000 after acquiring an additional 47,500 shares in the last quarter. KBC Group NV grew its stake in shares of Oscar Health by 41.2% in the third quarter. KBC Group NV now owns 4,552 shares of the company's stock valued at $97,000 after acquiring an additional 1,328 shares in the last quarter. Oppenheimer & Co. Inc. grew its stake in shares of Oscar Health by 175.3% in the third quarter. Oppenheimer & Co. Inc. now owns 70,806 shares of the company's stock valued at $1,502,000 after acquiring an additional 45,088 shares in the last quarter. Finally, Victory Capital Management Inc. grew its stake in shares of Oscar Health by 42.4% in the third quarter. Victory Capital Management Inc. now owns 58,353 shares of the company's stock valued at $1,238,000 after acquiring an additional 17,377 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently commented on OSCR. UBS Group began coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a "neutral" rating and a $23.00 price target on the stock. Bank of America downgraded shares of Oscar Health from a "neutral" rating to an "underperform" rating and decreased their price target for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Finally, Piper Sandler reaffirmed an "overweight" rating and set a $28.00 price objective on shares of Oscar Health in a research report on Tuesday, September 10th. One analyst has rated the stock with a sell rating, two have issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Oscar Health currently has an average rating of "Moderate Buy" and a consensus price target of $22.93.

Insider Activity

In other Oscar Health news, EVP Alessandrea C. Quane sold 16,793 shares of the stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $286,488.58. Following the completion of the sale, the executive vice president now owns 392,607 shares of the company's stock, valued at approximately $6,697,875.42. This represents a 4.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Vice Chairman Joshua Kushner bought 276,040 shares of the firm's stock in a transaction on Monday, November 11th. The shares were purchased at an average cost of $13.58 per share, with a total value of $3,748,623.20. Following the transaction, the insider now directly owns 5,031,262 shares in the company, valued at approximately $68,324,537.96. This trade represents a 5.80 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 1,055,478 shares of company stock valued at $14,432,852 and sold 150,360 shares valued at $2,645,074. 25.11% of the stock is currently owned by insiders.

Oscar Health Price Performance

Shares of OSCR stock traded down $1.03 on Wednesday, reaching $16.96. The company had a trading volume of 4,563,908 shares, compared to its average volume of 3,437,271. The stock has a market capitalization of $4.19 billion, a PE ratio of -282.95 and a beta of 1.63. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a one year low of $7.50 and a one year high of $23.79. The business's 50-day moving average is $17.18 and its 200 day moving average is $17.94.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The company had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. During the same period last year, the company posted ($0.29) EPS. The firm's revenue was up 68.3% compared to the same quarter last year. Equities research analysts forecast that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.